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Oklahoma had the 6th highest Opioid Overdose Death 
Rate in the United States in 2012. The Opioid Epidemic 
left Oklahoma with insurmountable loses and a solution 
was gravely needed. The solution in Oklahoma was 
thought to be Bill 1446, severely limiting the opioid 
prescribing practices of physicians. However, what many 
people do not know is that the Opioid Epidemic had 
already improved significantly by the time the bill passed 
in Oklahoma. According to the NIH, “In 2017, there were 
388 overdose deaths involving opioids in Oklahoma—a 
rate of 10.2 deaths per 100,000 persons”, compared to a 
death rate of 14.2 deaths per 100,000 persons in 2012. 
The most significant decline occurred among deaths 
involving prescription opioids, from 444 deaths in 2012 to 
251 deaths in 2017.” By this time, Oklahoma was  29th in 
the Opioid Overdose Death Rate rankings. 
Assess the drug use in patients enrolled in the trauma 
registry in a level II trauma center from November 1st, 
2017 – October 31st, 2019, one year prior and after the 
implementation of the Oklahoma Bill 1446. Assessing 
these outcomes will help clinicians better address proven 
risks and benefits of the new Opioid Prescribing Laws in 
Oklahoma. 
Retrospective Database Search SJMC 
November 1st 2017 – October 31st  2019
Inclusion Criteria:
• All Healthy Patients Enrolled in the Trauma Registry
• Positive Urine Drug Screen
Inclusion criteria needed to be enrolled in the trauma 
registry according to the American College of Surgeons 
and the National Trauma Data Bank include an injury 
other than “superficial” and the patient is admitted to 
the hospital or for surgery.
We chose Injury Severity Scale greater than 14 because 
patients with an ISS greater than or equal to 15 have a 
mortality of 10%. 
Bill 1446’s purpose was to combat the Opioid Epidemic. If 
this was the case and the law was effective then we 
should have seen a decrease in positive opioid drugs 
screens in trauma patients. However, there was no 
statistically significant differences in positive UDS from 
November 1st 2017-October 31st 2018 compared to 
November 1st 2018 – October 31st 2019 in any of the data 
pulled from the retrospective database search. We saw a 
rise in both positive opioid and amphetamine UDS 
percentages after the bill went into effect. We believe 
based off of the preliminary data and the findings from 
the CDC and NIH demonstrated that Oklahoma’s 
Prescription Opioid Problem significantly decreased by 
the end of 2017. Physicians’ opioid prescribing practices 
changed obviously however, positive opioid and 
amphetamine UDS percentages increased. We believe 
patients acquired narcotics illegally based off the 
combined CDC, NIH data and our own findings. So the 
question that should be asked “Will this Bill ever have the 
intended effect on physicians and patients across 
Oklahoma?” 
While these are preliminary findings, we are working on a 
multi-center retrospective chart review of all patients in 
the trauma registries while checking the Prescription 
Monitoring Program to cross reference which patients 
were previously prescribed opioids during their 
enrollment. 
Trauma Registry Data from St. John’s Medical Center
Comparing Drug Use in Trauma Patients
• Kaiser Family Foundation analysis of Centers for 
Disease Control and Prevention (CDC), National Center 
for Health Statistics. “Opioid Overdose Death Rates 
and All Drug Overdose Death Rates per 100,000 
Population (Age-Adjusted).” The Henry J. Kaiser Family 
Foundation, 16 Jan. 2019
• National Institute on Drug Abuse. “Oklahoma Opioid 
Summary.” NIDA, NIH, 29 Mar. 2019.
• Oklahoma Medical Board. “COMPLIANCE AND BEST 
PRACTICE FOR AN ACT REGULATING THE USE OF 
OPIOID DRUGS OKLAHOMA SENATE BILLS 1446 & 
848.” Oklahoma Medical Board, Oklahoma Medical 
Board, 3 June 2019.
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